**Company Registration Number. SC492045 (Scotland)**
**Fibromyalgia Action UK Unaudited financial statements and annual report For the year ended 30 November 2020**
**Fibromyalgia Action UK Contents**
**For the year ended 30 November 2020**
|**CONTENTS**|**PAGE**|
|---|---|
|Company Information|3|
|Director's Report|4|
|Accountant's Report|5|
|Income Statement|6|
|Statement of Financial Position|7|
|Notes to the Financial Statements|8 9|
|Detailed Income Statement|10|
- 2 -
**Fibromyalgia Action UK Company Information For the year ended 30 November 2020**
**Company registration number** SC492045 (Scotland) **Directors who served during the year** Glen Mcgregor **Registered office address** 12 Seedhill Road 3007 Mile End Mill Paisley PA1 1JS **Accountant** J Botham T and Acc Ltd Director Archer House, Britl Est Northbourne Road BN22 8PW
- 3 -
## **Fibromyalgia Action UK Director's Report**
## **For the year ended 30 November 2020**
The director presents the annual report and the Unaudited Financial Statement for the year ended 30 November 2020.
## **Principal activity**
The principal activity of the company continued to be that of provision of support and awareness of fibromyalga sufferers.
## **Going concern**
The financial statements have been prepared on a going concern basis unless it is inappropriate to presume that the company will continue in business.
## **Director of the company**
The following directors held office during the whole of the period: Glen Mcgregor
## **Statement of director's responsibilities**
The directors are responsible for preparing the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare such financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), FRS 102 1A.
Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to;
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
## **Small company provisions**
This report has been prepared in accordance with the special provisions for small companies within Part 15 of the Companies Act 2006.
## **Approved by the Board of directors and signed on its behalf by:**
Glen McGregor (Director) Date: 09 April 2021
- 4 -
## **Fibromyalgia Action UK Accountant's report For the year ended 30 November 2020**
Accountant's Report to the board of directors on the preparation of the unaudited statutory accounts of Fibromyalgia Action UK for the year ended 30 November 2020.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Fibromyalgia Action UK for the year ended 30 November 2020.
We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on these financial statements.
On the Statement of Financial Position, you have acknowledged your duties under the prevailing Companies Act 2006 that the company keeps adequate accounting records and prepares financial statements that give "a true and fair view".
You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.
The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.
J Botham T and Acc Ltd Director Archer House, Britl Est Northbourne Road BN22 8PW Date: 09 April 2021
- 5 -
## **Fibromyalgia Action UK Income Statement For the year ended 30 November 2020**
|**Notes**
Turnover
2
Cost of raw materials and consumables
**Gross profit**
Selling and distribution expenses
Administrative expenses
Other operating income
**Operating loss**
3
Interest receivable and similar income
**Loss on ordinary activities before taxation**
**Loss for the year**|**2020**
**£**
**2,834**
(1,239)
**1,595**
(963)
(108,778)
104,818
**(3,328)**
196
**(3,132)**
**(3,132)**|**2019**
**£**
**425**
(2,469)|
|---|---|---|
|||**(2,044)**
(3,272)
(87,655)
124,024|
|||**31,054**
282|
|||**31,335**|
|||**31,335**|
- 6 -
## **Fibromyalgia Action UK Statement of Financial Position**
## **For the year ended 30 November 2020**
|**Notes**
**Fixed assets**
Property, plant and equipment
5
**Current assets**
Inventories
6
Debtors
7
Corporation tax receivable
Cash and cash equivalents
8
**Current liabilities**
Creditors: Amounts falling due within one year
9
Net current assets/(liabilities)
Total assets less current liabilities
**Net assets/(liabilities)**
**Capital and reserves**
Retained earnings
**Shareholder's funds**|**2020**
**£**
590
590
2,420
6,041
58
281,118
289,637
(194)
(194)
289,443
290,033
**290,033**
290,033
**290,033**|**2019**
**£**
590|
|---|---|---|
|||590
2,420
7,230
284,369|
|||294,019
(1,444)|
|||(1,444)
292,575|
|||293,165|
|||**293,165**|
|||293,165|
|||**293,165**|
- For the year ended 30 November 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The director acknowledges his responsibility for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A Small Entities.
Approved by the Board on 09 April 2021
............................. Glen McGregor (Director) Company registration number: SC492045
- 7 -
## **Fibromyalgia Action UK Notes to the Financial Statements**
**For the year ended 30 November 2020**
## **(1) General Information**
Fibromyalgia Action UK is a private company limited by shares, domiciled and incorporated in England and Wales. Its registered office is 12 Seedhill Road, 3007 Mile End Mill, Paisley, PA1 1JS.
## **(2) Turnover**
The revenue from company's operations comprise:
|Sales
**) Operating profit**
Operating profit for the year from continuing operations has been arrived after charging:
Depreciation of property, plant and equipment
Staff costs|**2020**
**£**
2,834
**2,834**
**2020**
**£**
75,139
**75,139**|**2019**
**£**
425|
|---|---|---|
|||**425**|
|||**2019**
**£**
197
52,160|
|||**52,356**|
## **(3) Operating profit**
## **(4) Employees**
During the year, the average number of employees including director was 0 (2019 : 0) The above numbers are averages for the year and calculated on a fulltime equivalent basis. The aggregate payroll costs of the above were:
|Wages and salaries
Social security cost|**2020**
**£**
69,938
3,210
**73,147**|**2019**
**£**
50,981
832|
|---|---|---|
|||**51,813**|
## **(5) Tangible fixed assets**
|**Cost**
As at 01 December 2019
As at 30 November 2020
**Depreciation**
As at 01 December 2019|**Fixtures and Fittings**
**£**
5,215|**Totals**
**£**
5,215|
|---|---|---|
||**5,215**|**5,215**|
||4,626|4,626|
- 8 -
|As at 30 November 2020
**Net book value**
As at 30 November 2019
**(6) Inventories**
Stock of finished goods
**(7) Trade and other receivables**
**Amounts falling due within one year**
Trade debtors
Other debtors
Prepayments and accrued income
**(8) Cash and cash equivalents**
Bank balance
**(9) Trade and other payables**
Trade creditors
Accruals and deferred income
**(10) Called up share capital and reserves**
**Called up and fully paid:**
100 Ordinary shares of £1 each|**4,626**||**4,626**
590
**589**
**2019**
**£**
2,420
**2,420**
**2019**
**£**
7,198
32
**7,230**
**2019**
**£**
284,369
**284,369**
**2019**
**£**
1,368
76
**1,444**
**2019**
**£**
****|
|---|---|---|---|
||590|||
||**589**|||
|||**2020**
**£**
2,420
**2,420**
**2020**
**£**
294
3,979
1,768
**6,041**
**2020**
**£**
281,118
**281,118**
**2020**
**£**
194
**194**
**2020**
**£**
****||
- 9 -
**Fibromyalgia Action UK Notes to the financial statements (Continued) For the year ended 30 November 2020**
|**Retained earnings**|**2020**|
|---|---|
||**£**|
|At 1 December 2019|293,165|
|Loss of the year|(3,132)|
|At 30 November 2020|**290,033**|
|||
- 10 -
## **Fibromyalgia Action UK Detailed Income Statement For the year ended 30 November 2020**
|**Turnover**
**Less : Cost of raw materials and consumables**
Other direct expenses
Purchases
Transportation cost
Closing stock
Opening stock
**Gross Profit**
**Add : Other operating income**
Charities Aid Foundation Income
Donations Received
Fundraising Income
Non taxable income
Payroll Income
**Less : Selling and distribution expenses**
Advertising, sales promotion, marketing
Trustee Expenses
Volunteer Expenses
Travel and overseas travelling
**Less : Administrative expenses**
Accountancy fee
Bank, card and overdraft charges
Computer cost
Employee Salary expense
Employer NI
Equipment maintenance, rental and leasing
Insurance
Membership and subscriptions
Office Rental
Pension Contributions
Postage, stationery, office supplies
Professional, consultancy and legal fees
Sundry expenses
Telephone, internet and broadband
Training and development
Depreciation of fixtures and fittings
Rates
**Operating loss**
**Add : Interest receivable and similar income**
Bank interest receivable
**loss on ordinary activities before taxation**
**Net loss for the year after taxation**
**Net loss for the year after dividends**
**Retained profits brought forward**
**Retained profits carried forward**|**2020**
**£**
2,834
435
694
110
1,239
**1,595**
155
58,973
478
44,947
266
104,818
66
637
260
963
300
260
498
69,938
3,210
1,533
107
1,467
24,329
1,991
2,025
1,991
58
1,461
(390)
108,778
**(3,328)**
196
196
**(3,132)**
**(3,132)**
**(3,132)**
**293,165**
**290,033**|**2019**
**£**
425
1,474
1,099
(104)
(2,420)
2,420|
|---|---|---|
|||2,469|
|||**(2,044)**|
|||55
110,090
11,668
2,000
211|
|||124,024
1,365
1,067
242
598|
|||3,272
300
928
50,981
832
2,087
1,522
13,539
347
10,422
1,222
4,725
226
196
327|
|||87,655|
|||**31,054**|
|||282|
|||282|
|||**31,335**|
|||**31,335**|
|||**31,335**|
|||**261,829**|
|||**293,165**|
**This section does not form part of company's statutory financial statements.**
- 11 -